Sjögren syndrome is a hidden contributor of macrovascular and microvascular complications in patients with type 2 diabetes.
Yu-Jih SuPui-Ying LeongYu-Hsun WangJames Cheng-Chung WeiPublished in: International journal of rheumatic diseases (2022)
Sjögren syndrome is an unrecognized independent risk factor for cardiovascular events among diabetes patients, which indicates that patients with diabetes combined with Sjögren syndrome require closer follow up regarding cardiovascular complications in clinical settings. Treatment with hydroxychloroquine might not be enough to lower the cardiovascular risk significantly in diabetes patients with Sjögren syndrome.
Keyphrases
- cardiovascular events
- type diabetes
- case report
- end stage renal disease
- disease activity
- coronary artery disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- risk factors
- systemic lupus erythematosus
- metabolic syndrome
- glycemic control
- peritoneal dialysis
- skeletal muscle
- patient reported outcomes
- smoking cessation
- replacement therapy